Nature

SuperCom Wins New Project in Northern California Valued at up to $4.25 million

Retrieved on: 
Monday, November 28, 2022
COVID-19, E-government in Europe, Computer security, Nature, Organization, Case management, RFID, Texas Homecare, Companding, Government, Personal Data Privacy and Security Act of 2009, IOT, Annual report, Travel, Law enforcement, Health, Multi, Recidivism, LCA, Substance abuse, Safety, Form 6-K, Risk management

NEW YORK, Nov. 28, 2022 /PRNewswire/ -- SuperCom (NASDAQ: SPCB), a global provider of secured solutions for the e-Government, IoT, and Cybersecurity sectors, announced today that its fully-owned subsidiary, Leaders in Community Alternatives (LCA), has won a new project contract with a Northern California county to provide adult reentry services. LCA has provided services in this county for many years, including adult day reporting services and electronic monitoring.

Key Points: 
  • LCA has provided services in this county for many years, including adult day reporting services and electronic monitoring.
  • The contract focuses on reentry services, including case management, substance abuse education, job preparedness, and criminogenic risk reduction.
  • Project launch and generation of recurring revenues are expected to commence in the first half of 2023.
  • The win will go through a customary standstill waiting period before contract signing is approved and the project is launched.

China Focus releases a new feature on the COP27 and beyond

Retrieved on: 
Monday, November 28, 2022
Carbon, Climate change, COVID-19, GDP, COP27, Nature, Conference, Food, UN, Weather, Transport, Climate, Disaster, Drought, Pacific typhoon season, Wildfire, Agriculture, Beijing Review, Sharm El Sheikh, Water, UNFCCC, Flood, United Nations Framework Convention on Climate Change, ACMI, Recession, Renewable energy

BEIJING, Nov. 28, 2022 /PRNewswire/ -- China Focus releases a new feature on the COP27 and beyond.

Key Points: 
  • BEIJING, Nov. 28, 2022 /PRNewswire/ -- China Focus releases a new feature on the COP27 and beyond.
  • The feature is contributed by Zhong Cheng who is an op-ed contributor to Beijing Review and an expert on international studies.
  • The essence of combating climate change is to reduce greenhouse gas emissions, the main cause of rising temperatures.
  • China has been carrying out cooperation with other developing countries on adapting to climate change.

IDTechEx Discusses Three Applications for Electronic Skin Patches

Retrieved on: 
Monday, November 28, 2022
COVID-19, Consultant, Patient, ECG, Skin, Atrial fibrillation, Biotelemetry, Stroke, Conditional sentence, Communication, Nature, Philips, Prevalence, Risk, Fever, Caregiver, AF, Travel, Research, Disease, Neutropenia, Subscription business model, Baxter, Holter, Clinical trial, Pressure, Medical device, Pharmaceutical industry, LifeSigns: Surgical Unit

In their recent report " Electronic Skin Patches 2023-2033 ", market intelligence firm IDTechEx explores where these emerging devices can add value in different aspects of healthcare.

Key Points: 
  • In their recent report " Electronic Skin Patches 2023-2033 ", market intelligence firm IDTechEx explores where these emerging devices can add value in different aspects of healthcare.
  • IDTechEx discusses the industry activity in cardiac rhythm monitoring in their report " Electronic Skin Patches 2023-2033 ".
  • To learn more about electronic skin patches in vital sign monitoring, please refer to the IDTechEx report "Electronic Skin Patches 2023-2033".
  • IDTechEx's research, " Electronic Skin Patches 2023-2033 ", estimates that the electronic skin patch market will grow to over US$27bn by 2033.

IDTechEx Discusses Three Applications for Electronic Skin Patches

Retrieved on: 
Monday, November 28, 2022
COVID-19, Consultant, Patient, ECG, Skin, Atrial fibrillation, Biotelemetry, Stroke, Conditional sentence, Communication, Nature, Philips, Prevalence, Risk, Fever, Caregiver, AF, Travel, Research, Disease, Neutropenia, Subscription business model, Baxter, Holter, Clinical trial, Pressure, Medical device, Pharmaceutical industry, LifeSigns: Surgical Unit

In their recent report " Electronic Skin Patches 2023-2033 ", market intelligence firm IDTechEx explores where these emerging devices can add value in different aspects of healthcare.

Key Points: 
  • In their recent report " Electronic Skin Patches 2023-2033 ", market intelligence firm IDTechEx explores where these emerging devices can add value in different aspects of healthcare.
  • IDTechEx discusses the industry activity in cardiac rhythm monitoring in their report " Electronic Skin Patches 2023-2033 ".
  • To learn more about electronic skin patches in vital sign monitoring, please refer to the IDTechEx report "Electronic Skin Patches 2023-2033".
  • IDTechEx's research, " Electronic Skin Patches 2023-2033 ", estimates that the electronic skin patch market will grow to over US$27bn by 2033.

BIO-TECHNE TO PRESENT AT THE FIFTH ANNUAL EVERCORE ISI HealthCONx CONFERENCE

Retrieved on: 
Monday, November 28, 2022
Bio-Techne, EST, Gene editing, ELISA, Diagnosis, Nature, Antibody, Conference, Cytokine, Workflow, ACD, Research, ISH, Prostate cancer, Calendar, Drug discovery, FDA, Medical imaging

MINNEAPOLIS, Nov. 28, 2022 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that Chuck Kummeth, President and Chief Executive Officer, will present at the Fifth Annual Evercore ISI HealthCONx Conference on Tuesday, November 29, 2022, at 8:50 a.m. EST.

Key Points: 
  • MINNEAPOLIS, Nov. 28, 2022 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that Chuck Kummeth, President and Chief Executive Officer, will present at the Fifth Annual Evercore ISI HealthCONx Conference on Tuesday, November 29, 2022, at 8:50 a.m. EST.
  • A live webcast of the presentation can be accessed via the IR Calendar page of Bio-Techne's Investor Relations website at https://investors.bio-techne.com/ir-calendar .
  • These reagent and protein analysis solutions are sold to biomedical researchers as well as clinical research laboratories and constitute the Protein Sciences Segment.
  • With thousands of products in its portfolio, Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022 and has approximately 3,000 employees worldwide.

Sony AI Showcases the Latest Evolution of Gran Turismo Sophy™ at Gran Turismo® World Series 2022 Exhibition Race

Retrieved on: 
Monday, November 28, 2022
Software, PDI, SIE Worldwide Studios, Turismo, Ethics, PlayStation 4, SIE, PlayStation, Sony Interactive Entertainment, FIA-Certified Gran Turismo Championships, AI, Imagination, Race, Multimedia, Partnership, Creativity, Sony, Exhibition, GT7, Gran Turismo 7, Research, Family, Artificial intelligence marketing, Intelligence, PlayStation 5, Music, Medical device, Cassette tape, Bicycle, Video game console, Video game, Gran Turismo, Nature, Gastronomy

TOKYO, Nov. 28, 2022 /PRNewswire/ -- Sony AI showcased the newest evolution of Gran Turismo SophyTM (GT Sophy), its breakthrough autonomous AI racing agent, at the Gran Turismo® World Finals 2022 (GTWS 2022) organized by Polyphony Digital Inc. (PDI), which took place November 24-27 in Monaco.  

Key Points: 
  • TOKYO, Nov. 28, 2022 /PRNewswire/ -- Sony AI showcased the newest evolution of Gran Turismo SophyTM(GT Sophy), its breakthrough autonomous AI racing agent, at the Gran Turismo World Finals 2022 (GTWS 2022) organized by Polyphony Digital Inc. (PDI), which took place November 24-27 in Monaco.
  • The event featured a thrilling exhibition showdown between four of the world's top Gran TurismoTM(GT) drivers and GT Sophy.
  • GT Sophy is the first superhuman AI agent to outrace the world's best drivers of the Gran Turismo World Series.
  • Details on the Gran Turismo Sophy project, technology and the Race Together 2021 challenge races can be found at the Gran Turismo Sophy site .

L'OCCITANE Group announces its new corporate mission: to have a positive impact on people through empowerment and to regenerate nature

Retrieved on: 
Monday, November 28, 2022
Growth, Individual, Cosmetics, Nature, ESG, Empowerment, Articles of association, Article, Letter, Sale, Marketing, Management

Since its inception, the Group has curated a portfolio of entrepreneurial beauty brands all inspired by nature.

Key Points: 
  • Since its inception, the Group has curated a portfolio of entrepreneurial beauty brands all inspired by nature.
  • The new corporate mission represents the next phase in its ambitious transformation into a geographically balanced, multi-brand Group.
  • To regenerate nature: focuses on nature and how the positive actions of all employees can have a direct impact on it.
  • With its corporate mission firmly in place, L'OCCITANE Group will continue to harness and invest in the inherent strength of its brands.

L'OCCITANE Group announces its new corporate mission: to have a positive impact on people through empowerment and to regenerate nature

Retrieved on: 
Monday, November 28, 2022
Growth, Individual, Cosmetics, Nature, ESG, Empowerment, Articles of association, Article, Letter, Sale, Marketing, Management

Since its inception, the Group has curated a portfolio of entrepreneurial beauty brands all inspired by nature.

Key Points: 
  • Since its inception, the Group has curated a portfolio of entrepreneurial beauty brands all inspired by nature.
  • The new corporate mission represents the next phase in its ambitious transformation into a geographically balanced, multi-brand Group.
  • To regenerate nature: focuses on nature and how the positive actions of all employees can have a direct impact on it.
  • With its corporate mission firmly in place, L'OCCITANE Group will continue to harness and invest in the inherent strength of its brands.

Innovent Announced Clinical Data of Multiple Trials Will be Presented at the 2022 ESMO-IO and ASH Annual Meetings

Retrieved on: 
Monday, November 28, 2022
Autoimmune disease, Autoimmunity, Metastasis, Environment, CML, Medicine, Nature, NSCLC, Selpercatinib, Metabolic disorder, Hospital, Chemistry, CMC, Soochow University, TKI, Eli Lilly and Company, Mutation, First Affiliated Hospital of Xinjiang Medical University, Eli Lilly, Trial of the century, Ophthalmology, Peking Union Medical College, Ramucirumab, HKEX, Control, News, Tolerability, NDA, Efficacy, Cancer, Social conditions in Honduras, Integrity, Stock exchange, Main, MD Anderson Cancer Center, Sintilimab, Bevacizumab, The First Affiliated Hospital of Wenzhou Medical University, NMPA, Motherboard, Vaccine, Management, Pharmaceutical industry, Patient, Safety, Spotlight Innovation, Hematology, Incyte

On October 31, 2018, Innovent was listed on the Main Board of the Stock Exchange of Hong Kong Limited with the stock code: 01801.HK.

Key Points: 
  • On October 31, 2018, Innovent was listed on the Main Board of the Stock Exchange of Hong Kong Limited with the stock code: 01801.HK.
  • Since its inception, Innovent has developed a fully integrated multi-functional platform which includes R&D, CMC (Chemistry, Manufacturing, and Controls), clinical development and commercialization capabilities.
  • An additional 2 assets are under NMPA NDA review, 5 assets are in Phase 3 or pivotal clinical trials, and 20 more molecules are in clinical studies.
  • Innovent has built an international team with advanced talent in high-end biological drug development and commercialization, including many global experts.

TOURISMVERSE Is Bringing Tourism and Travel Industry on Web3

Retrieved on: 
Saturday, November 26, 2022
Nature, Republic, Belize Tourism Industry Association, Travel, Creative industries, Tourism, Metaverse, Sandbox

By utilizing the real-time experience advantages in respective destinations, metaverse capabilities in the tourist industry strive to enhance the travel experience of customers.

Key Points: 
  • By utilizing the real-time experience advantages in respective destinations, metaverse capabilities in the tourist industry strive to enhance the travel experience of customers.
  • To view an enhanced version of this graphic, please visit:
    The possibilities offered by tourismverse could allow people to travel the world from the comfort of their homes.
  • The tourismverse allows visitors to register for a variety of events, including:
    Bulut Bac, President of World Tourism Forum Institute emphasizes, "Today is a very important day for us and the Tourism Industry.
  • TourismX Project is supported by renowned World Tourism Forum Institute and World Tourism Fund & Investment (WTFI) Holding with global vision partners from all around the world.